
Monoclonal Antibody Center
Immunology Symposium in Honor of Bill C. Davis is May 22-23, 2023 – Celebrate Dr. Bill Davis’s illustrious career and the contributions to the veterinary immunology field.
The Monoclonal Antibody Center provides a range of services related to the production and characterization of monoclonal antibodies to researchers and clinicians affiliated with WSU.
Monoclonal antibodies to leukocyte differentiation molecules, activation molecules, and MHC Class I and II molecules in many species of food and companion animals have been produced by the WSU Monoclonal Antibody Center.
Taxonomic Key Program is a searchable database that allows researchers to easily identify monoclonal antibody-defined molecules by their physical characteristics.
For prices and availability or technical questions, contact Victoria Hulubei, 509-335-6058, or Dr. Bill C. Davis, lab director, 509-335-6051.
Monoclonal antibody production services
Catalog # | Description |
---|---|
MA2 | Production of monoclonal antibodies: Immunization of mice, collection of pre-immune and immune sera, screening of sera by ELISA, cell fusion to produce mAb producing hybridomas, identification and cryo-preservation of mAb positive hybridomas. |
MA3 | Cloning of hybridomas producing mAb of interest: Prepare and cryo-preserve 3 clones from each hybridoma cell line producing a mAb of interest. |
MA4 | Production of 500 mg monoclonal antibody. |
MA5 | Preparation of monoclonal antibody in serum free medium. |
Isotype controls
Catalog # | mAb | Ig isotype | E coli J5 |
---|---|---|---|
COL2001 | COLIS69A | IgG1 | E coli J5 |
COL2002 | COLIS205C | IgG2a | E coli J5 |
COL2003 | COLIS169A | IgG2b | E coli J5 |
COL2004 | COLIS41B | IgG3 | E coli J5 |
COL2005 | COLIS52A2 | IgM | E coli J5 |
Monoclonal antibodies by species
MoAb | Ig isotype | Specificity |
---|---|---|
H58A | G2a | MHC CL I |
PT85A | G2a | MHC CL I |
H42A | G2a | MHC CL II HLA-DP LIKE |
TH14B | G2a | MHC CL II HLA-DR |
TH81A | G2a | MHC CL II HLA-DQ |
TH97A | G2a | CD1b |
BAQ95A | G1 | CD2 |
MUC2A | G2a | CD2 |
CACT31A | CD2 | M |
MM1A | G1 | CD3 |
ILA-11A | G2a | CD4 |
GC50A | M | CD4 |
CACT138A | G1 | CD4 |
BAQ91A | G1 | CD6 |
BAQ83A | G2b | CD6 |
BAQ111A | M | CD8 |
CACT80C | G1 | CD8α |
7C2B | G2a | CD8α |
BAT72A | G1 | CD8β |
LT86A | G2a | CD9 |
B18A | G1 | CD9 |
RH1A | G3 | CD9 |
RACT48A | G2a | CD11a |
HUH73A | G1 | CD11a |
MM10A | G2b | CD11b |
MM12A | G1 | CD11b |
BAQ153A | M | CD11c |
CAM36A | G1 | CD14 LPS receptor (monocytes, variable on granulocytes in different species) |
CAM66A | M | CD14 LPS receptor (monocytes, variable on granulocytes in different species) |
LND37A | G1 | Monocytes |
LND68A | G1 | Monocytes |
BAQ30A | G1 | CD18 |
HUH82A | G2a | CD18 |
GB25A | G1 | CD21 |
TE1A | M | CD28 |
FW4-101 | G1 | CD29 |
ILA158A | G1 | CD40 |
CAPP2A | G1 | CD41 |
Bag40A | G3 | CD44 |
BAT31A | G1 | CD44 |
LT36A | G2b | CD44 |
LT41A | G2a | CD44 |
LCT27A | G1 | CD45R |
GS5A | G1 | CD45R |
GC6A | M | CD45R |
GC42A | G1 | CD45R0 |
ILA116A | G3 | CD45R0 |
TH17A | M | CD47 |
HUH71A | G1 | CD47 |
BAQ92A | G1 | CD62L |
DH59B | G1 | CD172a |
LND41A | G1 | DC and a subset of innate lymphoid cells |
B7A1 | M | WC1-N1 |
BAQ4A | G1 | WC1-N2 |
CACTB32A | G1 | WC1-N3 |
BAQ89A | G1 | WC1-N4 |
ILA29A | G1 | WC1 |
GB45A | G1 | WC1-N26 |
GB54A | G2a | WC1-N25 |
GB21A | G2b | TCR1-N24 δ chain specific |
CACTB6A | M | TCR1-N6 γ chain specific? |
CACT22B | G1 | TCR1-N7 γ chain specific? |
86D1 | G1 | TCR1-N7 cluster, γ chain specific? |
BIG73A | G1 | sIgM |
BIG715A | G1 | IgG1 |
BIG501E | G1 | λ light chain |
BAQ44A | M | B cells |
BAQ155A | G1 | B cells |
CH138A | M | Granulocytes |
MM20A | G1 | Granulocytes = CH138A |
GS23A | G1 | Neutrophils |
CACT108A | G2a | CD25 |
CACT116A | G1 | CD25 |
LCTB2A | G3 | CD25 |
LCTB32A | M | CD25 |
CACT26A | G2b | CD26 |
KTSN7A | G1 | CD69 |
ILA77A | M | CD71 |
CACT7A | M | ACT1 |
CACT200A | G1 | ACT1 |
CACT206A | G2a | ACT1 |
CACT26A | G1 | ACT2 |
LCTB6A | G1 | ACT9 |
GB110A | M | ACT16 |
CACT195A | M | ACT27 |
CACT216A | M | ACT28 |
CACT225A | G1 | ACT29 |
CACT152A | M | ACT31 |
CACT191A | M | ACT32 |
CACT180A | G1 | ACT34 |
CACT282A | M | ACT35 |
CACT153A | M | ACT37 |
CACT243A | M | ACT38 |
NK64A | G1 | NK Cluster 1 |
NK29A | G1 | NK Cluster 2 activation molecule |
NK47A | G2a | NK Cluster 2 |
FOX5A | G1 | Foxp3 |
FOX20A | G2b | FoxP3 |
Catalog # | Clone | Description | Ig isotype |
---|---|---|---|
AL-BOV2001 | H58A | MHC I | G2a |
AL-BOV2003 | H42A | MHC II | G2a |
AL-BOV2004 | TH14B | MHC II | G2a |
AL-BOV2005 | TH81A5 | MHC II | G2a |
LT2001 | LT1A | MHC II | G2a |
LT2002 | LT3A | CD5 like | G1 |
LT2003 | LT4A | CD5 like | G2a |
LT2004 | LT97A | Pan T | G2b |
LT2005 | LT10A | CD2/CD6 like | G2a |
LT2006 | LH43A | CD2/CD6 like | G1 |
AL-BOV2051 | GB45A | WC1-N26 | G1 |
AL-BOV2011 | GC50A | CD4 | M |
LT2007 | LT5A | CD8 | G2a |
LT2008 | LH41A | B | M |
LT2009 | LT79A | B sub | G3 |
LT2010 | LH7A | B sub | M |
LT2011 | LT78A | B sub | M |
LT2012 | LT48A | CD11a | G2a |
LT2013 | LT36A | CD44 | G2b |
LT2014 | LT41A | CD44 | G2a |
LT2015 | LT12A | CD45 like | G2a |
LT2016 | LH9A | ACT1 | M |
AL-BOV2027 | CAM36A | CD14 | G1 |
AL-BOV2029 | BAQ30A | CD18 | G1 |
AL-BOV2045 | TH17A | CD47 | M |
AL-BOV2049 | DH59B | CD172a | G1 |
Catalog # | Clone | Description | Ig isotype |
---|---|---|---|
CT-BOV2001 | H58A | MHC I | G2a |
CT-BOV2003 | H42A | MHC II | G2a |
CT-BOV2004 | TH14B | MHC II | G2a |
CT-BOV2005 | TH81A5 | MHC II | G2a |
CT2012 | CAT82A | MHC II | G1 |
CT2001 | CF54A | Pan T1 | G1 |
CT2002 | CF74A | Pan T2 | G1 |
CT2003 | CAT30A | CD4 | G1 |
CT2003 | CAT30A | CD4 | G1 |
CT2015 | CT1.572 (T572) | CD5 | G2a |
CT2013 | CTOKT8 | CD8 | G2a |
CT2004 | 25-2A | CD8 | G1 |
CT2014 | CT3.357 (T357) | CD8β | M |
CT-BOV2021 | RH1A | CD9 | G3 |
CT-BOV2027 | CAM36A | CD14 | G1 |
CT-BOV2029 | BAQ30A | CD18 | G1 |
CT-BOV030 | HUH82A | CD18 | G2a |
CT2005 | F46A | CD21 | G1 |
CT2006 | CL2A | CD41 Platelets | G1 |
CT2007 | H22A | CD44 | GI |
CT-BOV2037 | BAG40A | CD44 | G3 |
CT-BOV2049 | DH59B | CD172a | G1 |
CT2008 | CF26A | Pan lymphocyte | G1 |
CT2011 | CL35A | granulocyte | G1 |
CT2015 | CF7A | T sub | G1 |
CT2016 | F72A | Granulocytes, monocytes, B | G1 |
Catalog # | Clone | Description | Ig isotype |
---|---|---|---|
BOV2001 | H58A | MHC CL I | G2a |
BOV2002 | PT85A | MHC CL I | G2a |
BOV2122 | B5C | MHC CL I | G2b |
BOV2125 | W6/32 | MHC CL I | G2a |
BOV2120 | H1A | MHC I | G2a |
BOV2131 | H6A | MHC I | G2a |
BOV2003 | H42A | MHC CL II | G2a |
BOV2004 | TH14B | MHC CL II BoLA-DR | G2a |
BOV2005 | TH81A | MHC CL II BoLA-DQ | G2a |
BOV2117 | H34A | MHC CL II | G2b |
BOV2114 | BAQ150A | MHC II | G3 |
BOV2115 | TH16A | MHC II | G2a |
BOV-CT2012 | CAT82A | MHC II | G1 |
BOV2007 | BAQ95A | CD2 | G1 |
BOV2008 | MUC2A | CD2 | G2a |
BOV2113 | 16-1E10 | CD2 | G1 |
BOV2123 | CH134A | CD2 | G2a |
BOV2003 | H42A | MHC CL II | G2a |
BOV2004 | TH14B | MHC CL II BoLA-DR | G2a |
BOV2005 | TH81A | MHC CL II BoLA-DQ | G2a |
BOV2117 | H34A | MHC CL II | G2b |
BOV2114 | BAQ150A | MHC II | G3 |
BOV2115 | TH16A | MHC II | G2a |
BOV-CT2012 | CAT82A | MHC II | G1 |
BOV2007 | BAQ95A | CD2 | G1 |
BOV2008 | MUC2A | CD2 | G2a |
BOV2113 | 16-1E10 | CD2 | G1 |
BOV2123 | CH134A | CD2 | G1 |
BOV2009 | MM1A | CD3 | G1 |
BOV2010 | IL11A | CD4 | G2a |
BOV2011 | GC50A | CD4 | M |
BOV2012 | CACT138A | CD4 | G1 |
BOV2116 | CACT83B | CD4 | M |
BOV2013 | B29A | CD5 | G2a |
BOV2014 | CACT105A | CD5 | G1 |
BOV2015 | BAQ91A | CD6 | G1 |
BOV2016 | BAQ83A | CD6 | G2b |
BOV2017 | CACT80C | CD8α | G1 |
BOV2018 | CACT130A | CD8α | G3 |
BOV2019 | 7C2B | CD8α | G2a |
BOV2097 | BAQ111A | CD8α | M |
BOV2020 | BAT82A | CD8β | G1 |
BOV2021 | RH1A | CD9 | G3 |
BOV2111 | B18A | CD9 | G3 |
BOV2112 | LT86A | CD9 | G2a |
BOV2023 | HUH73A | CD11a | G1 |
BOV2024 | MM10A | CD11b | G2b |
BOV2025 | MM12A | CD11b | G1 |
BOV2026 | BAQ153A | CD11c | M |
BOV2066 | BAQ151A | CD11c | G1 |
BOV2124 | MM31A | CD11c | M |
BOV2027 | CAM36A | CD14 | G1 |
BOV2028 | CAM66A | CD14 | M |
BOV2109 | MM61A | CD14 | G1 |
BOV2029 | BAQ30A | CD18 | G1 |
BOV2030 | HUH82A | CD18 | G2a |
BOV2031 | GB25A | CD21 | G1 |
BOV2032 | BOV2032 | CD21 | M |
BOV2073 | CACT108A | CD25 | G2a |
BOV2074 | CACT116A | CD25 | G1 |
BOV2075 | GB112A | CD25 | G1 |
BOV2076 | LCTB2A | CD25 | G3 |
BOV2077 | LCTB32A | CD25 | M |
BOV2078 | CACT114A | CD26 | G2b |
BOV2136 | NK29A | CD26 | G1 |
BOV2137 | NK47A | CD26 | G2a |
BOV2033 | TE1A | CD28 | M |
BOV2034 | FW4-101 | CD29 | G1 |
BOV2107 | ILA158A | CD40 | G1 |
BOV2036 | CAPP2A | CD41 | G1 |
BOV2037 | BAG40A | CD44 | G3 |
BOV2038 | BAT31A | CD44 | G1 |
BOV2039 | CACTB51A | CD45 | G2a |
BOV2040 | GS5A | CD45R | G1 |
BOV2041 | GC6A | CD45R | M |
BOV2042 | ILA116A | CD45R0 | G3 |
BOV2043 | GC42A | CD45R0 | G1 |
BOV2044 | HUH71A | CD47 | G1 |
BOV2045 | TH17A | CD47 | M |
BOV2079 | FW3-218 | CD49d | G2b |
BOV2134 | CACT180A | CD50 | G1 |
BOV2135 | CACT216A | CD50 | M |
BOV2046 | BAQ92A | CD62L | G1 |
BOV2080 | KTSN7A | CD69 | G1 |
BOV2081 | ILA77A | CD71 | M |
BOV2047 | ILA159 | CD80 | G1 |
BOV2048 | ILA190A | CD86 | G1 |
BOV2141 | LND68A | CD163 | G1 |
BOV2049 | DH59B | CD172a | G1 |
BOV2105 | ILA53A | CD205 | G2a |
BOV2106 | ILA114A | CD205 | G1 |
BOV2133 | 209MD26A | CD209 | G2a |
BOV2058 | GB21A | TCR1-N24 d chain specific | G2b |
BOV2059 | CACT61A | TCR1-N12 d chain specific | M |
BOV2056 | CACTB6A | TCR1-N6 γ chain specific? | M |
BOV2057 | CACTB81A | TCR1-N7 γ chain specific? | G1 |
BOV2050 | B7A | WC1+ γδ T cell N1 epitope | M |
BOV2053 | BAQ4A | WC1+ γδ T cell N2 epitope | G1 |
BOV2052 | GB54A | WC1+ γδ T cell N25 epitope | G2a |
BOV2054 | CACTB32A | WC1+ γδ T cell N3epitope | G1 |
BOV2121 | CACTB7A | WC1+ γδ T cell N3 subset | G1 |
BOV2055 | BAQ89A | WC1+ γδ T cell N4 epitope | G1 |
BOV2119 | BAQ159A | WC1+ γδ T cell N4 subset | G1 |
BOV2093 | BAG2B | WC1+ γδ T cell N27 epitope | M |
BOV2094 | BAG25A | WC1+ γδ T cell N28 epitope | M |
BOV2098 | CACTB21A | WC1+ γδ T cell N29 epitope | G1 |
BOV2099 | CACTB31A | WC1+ γδ T cell N30 epitope | G2b |
BOV2101 | CACT21A | WC1+ γδ T cell N31 epitope | G1 |
BOV2118 | ILA29 | WC1+ γδ T cell | G1 |
BOV2060 | PIG45A | sIgM | G2b |
BOV2061 | BIG73A | sIgM | G1 |
BOV2062 | BIG715A | IgG1 | G1 |
BOV2063 | BIG501E | l light chain | G1 |
BOV2064 | BAQ44A | B cells | M |
BOV2102 | GB26A | B cells | M |
BOV2126A | BAQ155A | B cells (sIgM?) | G1 |
BOV2067 | CH138A | Neutrophils | M |
BOV2068 | MM20A | Neutrophils = CH138A | G1 |
BOV2070 | BIB | ab and gd T cells | M |
BOV2071 | TH18A | Pan lymphocyte | G3 |
BOV2072 | GB50A | Pan leukocyte, endothelial cells | G1 |
BOV2082 | CACT200A | SLAMF9 (ACT 1) | G1 |
BOV2083 | CACT206A | SLAMF9 (ACT 1) | G2a |
BOV2092 | FOX5A | Foxp3 | G1 |
BOV2103 | GB53A | Gr, mono/ lymph sub | G1 |
BOV2104 | GC34A | Lymphocytes, monocytes | M |
BOV2132 | NK64A | Gp96 | G1 |
BOV2138 | BAQ56A | Platelets | G1 |
BOV2139 | BAQ125A | Platelets | G2b |
BOV2140 | GC5A | Platelets | G1 |
MoAb | Ig isotype | Specificity |
---|---|---|
AV64A | G1 | MHC CL II |
AV67A | G1 | αβ TCR? |
AV261A | G3 | Pan T |
AV66D | G3 | CD4 |
AV92A | M | CD4 |
AV309C | G1 | CD4 |
AV213A | G2a | CD8 |
AV319A | G1 | CD8 |
AV47A | M | sIgM |
AV191A | M | Late B |
AV306B | G1 | Granulocyte, monocyte |
AV243A | G2a? | Granulocyte, monocyte |
AV129A | M | Pan leukocyte |
AV14A | M | Pan leukocyte |
AV3A | M | Pan leukocyte + RBC |
AV18A | M | Pan leukocyte + RBC |
AV36A | M | Pan leukocyte + RBC |
AV43A | G3 | Pan leukocyte + RBC |
AV114A | M | Thrombocyte |
Catalog # | Clone | Description | Ig isotype |
---|---|---|---|
DG-BOV2001 | MHC I | DG-H58A | G2a |
DG-BOV2003 | MHC II | DG-H42A | G2a |
DG-BOV2004 | MHC II | DG-TH14B | G2a |
DG-BOV2005 | MHC II | MHC II | G2a |
DG2001 | DH29A | CD4 | M |
DG2002 | CADO46A | CD8 | G1 |
DG2003 | DH3B | CD5 | G1 |
DG2014 | DH13A | CD5 | M |
DG-BOV2021 | RH1A | CD9 | G3 |
DG-BOV2027 | CAM36A | CD14 | G1 |
DG-BOV2023 | HUH73A | CD11a | G1 |
DG-BOV2029 | BAQ30A | CD18 | G1 |
DG-BOV2030 | HUH82A | CD18 | G2a |
DG-CT2005 | F46A | CD21 | G1 |
DG2004 | DLL20A | B and granulocytes | M |
DG2005 | DLL51A | B | G1 |
DG2006 | DLL76A | B | G1 |
DG2007 | DLL132A | B | M |
DG-CT2007 | H22A | CD44 | G2a |
DG-BOV2037 | BAG40A | CD44 | G3 |
DG-2008 | CADO18A | CD unknown pan leukocyte | G1 |
DG-2009 | DH16A | CD45RB | N |
DG2010 | CADO21A | CD unknown pan leukocyte | G2b |
DG2011 | DH2A | CD90 | M |
DG2015 | DH24A | CD90 | M |
DG-BOV2049 | DH59B | CD172a | G1 |
DG-CT2006 | CL2A | CD41 | G1 |
DG2012 | CADO48A | Neutrophils | G1 |
DG2016 | CADO19A | CD45 predicted | G1 |
Catalog # | Clone | Description | Ig isotype |
---|---|---|---|
G-Bov2001 | MHC CL I | H58A | G2a |
G-Bov2002 | MHC CL I | PT85A | G2a |
G-Bov2003 | MHC CL II HLA-DP like | H42A | G2a |
G-Bov2004 | MHC CL II BoLA-DR | TH14B | G2a |
G-Bov2005 | MHC CL II BoLA-DQ | TH81A | G2a |
G-Bov2006 | CD1b | TH97A | G2a |
G-Bov2007 | CD2 | BAQ95A | G1 |
G-Bov2008 | CD2 | MUC2A | G2a |
GT2001 | GC1A | CD4 | G2a |
G-BOV2011 | GC50A | CD4 | M |
GT2002 | 17D | CD4 | G1 |
GT2003 | BAGB45A | CD5 | G1 |
G-BOV2015 | BAQ91A | CD6 | G1 |
G-BOV2017 | CACT80C | CD8α | G1 |
G-BOV2019 | 7C2B | CD8α | G2a |
G-BOV2020 | BAT82A | CD8β | G1 |
G-BOV2023 | HUH73A | CD11a | G1 |
G-BOV2025 | MM12A | CD11b | G1 |
G-BOV2026 | BAQ153A | CD11c | M |
G-BOV2029 | BAQ30A | CD18 | G1 |
G-BOV2031 | GB25A | CD21 | G1 |
G-BOV202034 | FW4-101 | CD29 | G1 |
G-BOV2036 | CAPP2A | CD41 | G1 |
G-BOV2027 | CAM36A | CD14 | G1 |
G-BOV2028 | CAM66A | CD14 | M |
G-BOV2037 | BAG40A | CD44 | G3 |
G-BOV2040 | GS5A | CD45R | G1 |
G-BOV2041 | GC6A | CD45R | M |
G-BOV2042 | ILA116A | CD45R0 | G3 |
G-DG2009 | DH16B | CD45RB | G1 |
G-BOV2045 | TH17A | CD47 | M |
G-BOV2079 | FW3-218 | CD49d | G2b |
GT2010 | DU1-29 | CD62L | G1 |
G-BOV2058 | GB21A | TCR1 δ chain | G2b |
G-BOV2056 | CACTB6A | TCR1-N6 γ chan? | M |
G-GT2011 | 86D | TCR1-N6 γ chan? | G1 |
G-BOV2050 | B7A1 | WC1-(N1 epitope) | M |
G-BOV2053 | BAQ4A | WC1-(N2 epitope) | G1 |
G-BOV2054 | CACTB32A | WC1-(N3 epitope) | G1 |
G-BOV2055 | BAQ89A | WC1-( N4 epitope) | G1 |
G-BOV2052 | GB54A | WC1-(N25 epitope) | G2a |
G-BOV2051 | GB45A | WC1-(N26 epitope) | G1 |
G-BOV2060 | PIG45A2 | IgM | G2b |
G-BOV2062 | BIG715A | IgG1 | G1 |
G-BOV2063 | BIG501E | λ chain | G1 |
G-BOV202064 | CACT116A | B (B-B2) | M |
G-BOV2074 | CACT116A | CD25 | G1 |
G-BOV2075 | GB112A | CD25 | G1 |
G-BOV2076 | LCTB2A | CD25 | G3 |
G-BOV2038 | BAT31A | CD44 | G1 |
G-BOV2012 | GB26A | B cells | M |
G-BOV212 | ILA29 | WC1 | G1 |
GT2012 | CVR18A | Lymphocytes mono | G1 |
GT2013 | BAGB20A | CD45 predicted | G1 |
Catalog # | Clone | Description | Ig isotype |
---|---|---|---|
HM-BOV2003 | MHC II | H42A | G2a |
HM2001 | MHC II | HAT19A | G1 |
HM2002 | Pan T | HAT19A | G1 |
HM2003 | Pan T = HAB2A | HAT19A | G2a |
HM2004 | HAB1A | CD4 predicted | G1 |
HM2005 | HAL36A | CD4 predicted | G2a |
HM2006 | HAL17A | B | G2a |
HM2007 | HASA7A | B | G1 |
HM2008 | HAT3A | B | M |
HM2009 | HAB6B | Pan lymphocyte | G2a |
HM2010 | HASA18A | Pan lymphocyte | M |
HM-BOV2029 | BAQ30A | CD18 | G1 |
HM2011 | HASA25A | CD45 predicted | G1 |
HM2012 | HAT13A | CD45 predicted | G2b |
Catalog # | Clone | Description | Ig isotype |
---|---|---|---|
HR-BOV2001 | H58A | MHC I | G2a |
HR-BOV2002 | PT85A | MHC I | G2a |
HR-BOV2003 | H42A | MHC II | G2a |
HR-BOV2004 | TH14B | MHC II | G2a |
HR-BOV2005 | TH81A5 | MHC II | G2a |
HRS2001 | HB88A | CD2 | G1 |
HRS2002 | HB61A | CD4 | G1 |
HRS2003 | HB65A | CD4 sub | G2a |
HRS2004 | HB86A | CD4 sub | G1 |
HRS2005 | HB19A | CD5 | G2a |
HRS2006 | HT23A | CD5 | G1 |
HRS2007 | HT14A | CD8β | G1 |
HRS2008 | ETC142B1A | CD8α | G2a |
HRS2017 | 73/6.9.1 | CD8α | G3 |
HR-BOV2023 | HUH73A | CD11a | G1 |
HRS2010 | H20A | CD18 | G1 |
HR-BOV2037 | BAG40A | CD44 | G3 |
HR-BOV2038 | BAT31A | CD44 | G1 |
HRS2011 | HB32A | CD45R0 predicted | G2a |
HRS2012 | HB72A | CD45R0 predicted | G2a |
HRS2013 | E38A | CD45R0 predicted | G1 |
HR-DG2009 | DH16A | CD45RB | M |
HR-BOV2049 | DH59B | CD172a | G1 |
HR-BOV2013 | B29A | B polymorphic (CD5 in bov) | G2a |
HR-DG2011 | DH24A | Granulocytes | M |
HRS2016 | HACT39A | Granulocytes | G1 |
HRS2018 | 1.9/3.2 | sIgM | G1 |
Catalog # | Clone | Description | Ig isotype |
---|---|---|---|
PG2001 | 74-11-10 | MHC CL I | G2b |
P-BOV2002 | PG-PT85A | MHC CL I | G2a |
PG2004 | PG-TH21A | MHC II | G2b |
PG2005 | PG-TH22A | MHC II | G2a |
PG2006 | MSA3 | MHC II | G2a |
PG-BOV2003 | PG-H42A | MHC II | G2a |
PG-BOV2005 | P-TH81A5 | MHC II DQ orthologue | G2a |
PG2007 | MSA4 | CD2 | G2a |
PG2008 | PGBL23A | CD2 | G1 |
PG2009 | PG168A | CD2 | G3 |
PG2010 | 8E6 | CD3 | G1 |
PG2011 | 8E6-2b3c | CD3 | G2a |
PG2012 | 8E6-8C8 | CD3 | G2a |
PG2013 | PT90A | CD4 | G2a |
PG2014 | 74-12-4 | CD4 | G2b |
PG2015 | PG114A | CD5 | G1 |
PG2016 | PG90A | CD6 | G1 |
PG2017 | PT36A | CD8α | G1 |
PG2018 | PT81B | CD8α | G2b |
PG2019 | 76-2-11 | CD8α | G2a |
PG2020 | PG164A | CD8β | G2a |
PG2021 | MUC76A | CD11a | G2a |
PG-BOV2027 | PG-CAM36A | CD14 | G1 |
PG2022 | PG-BAQ30A | CD18 | G1 |
PG-BOV2030 | PG-HUH82A | CD18 | G2a |
PG2023 | PGBL25A | CD25 | G1 |
PG2050 | PG124A | CD27 (SWC2) | G1 |
PG-BOV2034 | PG-FW4-101 | CD29 | G1 |
PG-BOV2037 | PG-BAG40A | CD44 | G3 |
PG-BOV2038 | PG-BAT31A | CD44 | G1 |
PG2024 | 74-9-3A1 | CD45 | M |
PG2025 | PG77A | CD45RA | M |
PG2026 | PG96A | CD45RA | G1 |
PG2027 | PG97A | CD45RA | M |
PG2028 | PG167A | CD45RA | G1 |
PG2029 | PGB78A | CD45RA | G2a |
PG-BOV2044 | PG-HUH71A | CD47 | G1 |
PG-BOV2045 | PG-TH17A | CD47 | M |
PG2030 | MUC93A | CD59 | G1 |
PG2031 | 74-22-15A | CD172a (SWC3) | G2b |
PG2049 | 74-22-15 | CD172a (SWC3) | G1 |
PG-BOV2049 | DH59B | CD172a (SWC3) | G1 |
PG2032 | PGBL22A | TCR1 δ chain specific | G1 |
PG2033 | PT14A | TCR1 subset | G2a |
PG2034 | PT79A | TCR1 subset | G2a |
PG2035 | MUC127A | TCR1 subset | G2a |
PG2036 | PG83A | SWC4 | G3 |
PG2037 | PG92A | SWC5 | M |
PG2038 | PG94A | Subset SWC6+ γδ T cells | M |
PG2039 | PGBL24A | Subset γδ T cells | M |
PG2040 | PGBL31A | Subset γδ T cells | G1 |
PG2041 | PG74C | Subsets γδ CD4 CD8 T cells | M |
PG2042 | PG104A | CD8+ CD4 sub, γδ small sub | M |
PG2043 | 76-7-4 | B cell and thymocytes | G2a |
PG2045 | PG68A | Granulocytes | G1 |
PG2046 | PG145A | sIgM | M |
PG-BOV2060 | PIG45A2 | sIgM | G2b |
PG2047 | PG89A | Pan lymphocyte | G1 |
PG2048 | PG106A | Pan lymphocyte | M |
Catalog # | Clone | Description | Ig isotype |
---|---|---|---|
R-BOV2001 | R-H58A | MHC I | G2a |
R-BOV2004 | R-TH14B | MHC II | G2a |
RB2001 | RTH2A | T1 | G1 |
RB2002 | RTH21A | T2 | G1 |
RB2003 | RT22A | T2 blocked RTH21A | M |
RB2004 | MRB61A | T3 | G1 |
RB2005 | RTH26A | T4 = ken5 | G2a |
RB2006 | RTH1A | CD4 | G1 |
RB2007 | RTH192A | CD5 | G1 |
RB2008 | ISC16A | CD8 | M |
RB2009 | ISC27A | CD8 | G2a |
RB2010 | ISC29E | CD8 | G1 |
RB2011 | ISC38A | CD8 | G1 |
R-BOV2021 | RH1A | CD9 | G3 |
R-BOV2023 | HUH73A | CD11a | G1 |
RB2021 | RT18A | CD11b | M |
R-BOV2027 | CAM36A | CD14 | G1 |
R-BOV2029 | BAQ30A | CD18 | G1 |
R-BOV2030 | HUH82A | CD18 | G2a |
R-BOV2037 | BAG40A | CD44 | G3 |
RB2022 | ISC18A | CD45 | G2a |
RB2023 | ISC39A | CD45 | G1 |
RB2024 | ISC76A | CD45 | M |
RB2025 | RTH32A | CD58 | M |
RB2026 | RTH33A | CD58 | G1 |
RB2012 | RACT19A | CD4 CD8 SUB CD28? | M |
RB2013 | RACT20A | Basophils and sub CD4 CD8 | G1 |
RB2014 | MRB120A | Granulocytes, basophils, monocytes | G1 |
RB2015 | MRB25A | B | M |
RB2031 | MRB143A | B | M |
R-BOV2064 | BAQ44A | BAQ44A | M |
RB2017 | RT19A | B sub | M |
RB2018 | MRB107A | B sub | G1 |
RB2019 | MRB102A | Pan lymphocyte | M |
RB2020 | RTH186A | Pan lymphocyte | G1 |
RB2027 | RACT44A | Granulocytes | M |
RB2028 | RACT38A | Pan leukocyte | G1 |
Catalog # | Clone | Description | Ig isotype |
---|---|---|---|
S-BOV2001 | H58A | MHC CL I | G2a |
S-BOV2002 | PT85A | MHC CL I | G2a |
S-BOV2003 | H42A | MHC CL II | G2a |
S-BOV2004 | TH14B | MHC CL II BoLA-DR | G2a |
S-BOV2005 | TH81A | MHC CL II BoLA-DQ | G2a |
S-BOV2006 | TH97A | CD1b | G2a |
S-BOV2008 | MUC2A | CD2 | G2a |
S-GT2001 | GC1A | CD4 | G2a |
S-BOV2011 | GC50A | CD4 | M |
S-GT2002 | 17D | CD4 | G1 |
SHP2001 | ST1A | CD5 | IgG2a |
SHP2002 | ST8 | CD8 | M |
S-BOV2017 | CACT80C | CD8α | G1 |
S-BOV2019 | 7C2B | CD8α | G2a |
S-BOV2020 | BAT82A | CD8β | G1 |
S-BOV2023 | HUH73A | CD11a | G1 |
S-BOV2025 | MM12A | CD11b | G1 |
S-BOV2026 | BAQ153A | CD11c | M |
S-BOV2029 | BAQ30A | CD18 | G1 |
S-BOV2034 | FW4-101 | CD29 | G1 |
S-BOV2036 | CAPP2A | CD41 | G1 |
S-BOV2027 | CAM36A | CD14 | G1 |
S-BOV2028 | CAM66A | CD14 | M |
S-BOV2037 | BAG40A | CD44 | M |
S-BOV2040 | GS5A | CD45R | G1 |
S-BOV2041 | GC6A | CD45R | M |
S-BOV2042 | ILA116A | CD45R0 | G3 |
S-DH2009 | DH16B | CD45RB | M |
S-BOV2045 | TH17A | CD47 | M |
S-BOV2079 | FW3-218 | CD49d | G2b |
S-GT2010 | DU1-29 | CD62L | G1 |
S-BOV2056 | CACTB6A | TCR1-N6 γ chain ? | M |
S-GT2011 | 86D | TCR1 γ chain ? | G1 |
S-BOV2050 | B7A1 | WC1-N1 | M |
S-BOV2053 | BAQ4A | WC1-N2 | G1 |
S-BOV2121 | CACTB7A | WC1-N3 | G1 |
S-BOV2055 | BAQ89A | WC1-N4 | G1 |
S-BOV2052 | GB54A | WC1-N25 | G2a |
S-BOV2051 | GB45A | WC1-N26 | G1 |
S-BOV2060 | PIG45A2 | sIgM | G2b |
S-BOV2062 | BIG715A | G1 | G1 |
S-BOV2063 | BIG501E | λ chain | G1 |
S-BOV2064 | BAQ44A | B (B-B2) | M |
S-BOV2074 | CACT116A | CD25 | G1 |
S-BOV2075 | GB112A | CD25 | G1 |
S-BOV2076 | LCTB2A | CD25 | G3 |
S-CT2012 | CAT82A | MHC II | G1 |
MoAb | Ig isotype | Specificity |
---|---|---|
PT85A | G2a | MHC Cl I |
H58A | G2a | MHC Cl I |
H42A | G2a | MHC Cl II |
TH14B | G2a | MHC Cl II |
TH81A5 | G2a | MHC Cl II |
BAQ95A | G1 | CD2 |
MUC2A | G2a | CD2 |
MM1A | G1 | CD3 |
CACT138A | G1 | CD4 |
GC50A1 | M | CD4 |
ILA11A | G2a | CD4 |
BAQ91A | G1 | CD6 |
CACT80C | G1 | CD8α |
CACT88C | G3 | CD8α? |
7C2B | G2a | CD8α? |
TH82A | G1 | CD8β? |
TH2A | G2a | CD9 |
B18A | G3 | CD9 |
HUH73A | IgG1 | CD11a |
MM12A | G1 | CD11b |
BAQ153A | M | CD11c |
CAM36A | G1 | CD14 |
BAQ30A | G1 | CD18 |
HUH82A | IgG2a | CD18 |
GB25A | G1 | CD21 |
CACT116A | G1 | CD25 |
LCTB2A | G3 | CD25 |
GB112A | G1 | CD25 |
CACT114A | G2b | CD26 |
BAT31A | G1 | CD44 |
LT36A | G2b | CD44 |
LCT27A | G1 | CD45R |
ILA116A | G3 | CD45R0 |
TH17A | M | CD47 |
BAQ92A | G1 | CD62L |
DH59B | G1 | CD172a |
GB21A1 | G2b | γδ TCR-N24 δ chain |
CACTB6A | M | γδ TCR-N6 γ chain? |
CACTB81A | G1 | γδ TCR-N7 γ chain? |
CACTB44A | G1 | γδ TCR-N7 CL |
B7A1 | M | WC1-N1 |
CGB24A | G1 | WC1-N1 CL |
BAQ4A | G1 | WC1-N2 |
CACTB32A | G1 | WC1-N3 |
BAQ89A | G1 | WC1-N4 |
BAQ159A | G1 | WC1-N4 CL |
CACTB31A | G2b | WC1-N22 |
GB54A | G2a | WC1-N25 |
GB45A | G1 | WC1-N26 |
PIG45A2 | G2b | IgM |
BIG501E | G1 | λ light chain |
BAQ44A | M | B-B2 |
GB26A | M | B + T sub |
LND37A | G1 | M |
LND68A | G1 | M |
CH138A | M | Gr + endo |
MM20A | G1 | Gr + endo = CH138A |
CACT200A | G1 | ACT1 |
CACT206A | G2a | ACT1 |
CACT298A | G2a | ACT1 |
LCTB6A | G1 | ACT9 |
GB110A | M | ACT16 |
CACT216A | M | ACT28 |
CACT225A | G1 | ACT29 |
CACT152A | M | ACT31 |
CACT191A | M | ACT32 |
CACT180A | G1 | ACT34 |
CACT282A | M | ACT35 |
CACT153A | M | ACT37 |
CACT243A | M | ACT38 |
About us
In the mid-70s, a group of investigators demonstrated in mice that it is possible to immortalize B lymphocytes producing single monospecific antibodies (mAbs) by fusing B lymphocytes to tissue culture adapted myeloma (malignant form of an antibody producing cell) cells. The hybrid cells (hybridomas) were stable and could be maintained in culture indefinitely or preserved in liquid nitrogen for later use. These findings represented a major breakthrough in the way antibody reagents could be developed for basic and biomedical research. Mice could be immunized with antigens of interest and then used as a source of B lymphocytes to produce mAbs of known specificity. The spleen was shown to be the best source of B lymphocytes for making hybridomas. Hybridomas producing the desired mAbs could be identified by examining culture medium from primary cultures of fused cells. In subsequent investigations, myeloma fusion partners were developed that could only grow in selective growth medium if fused to a B lymphocyte, eliminating the problem of distinguishing hybridomas from cells that had not fused with a B lymphocyte. Myeloma fusion partners were later identified that could no longer produce their own antibody but could produce antibody derived from the B lymphocyte. These advances simplified and improved the methodology for producing mAbs.
Research universities, research institutes and industry established core facilities to exploit mAb technology to develop mAbs for use as analytical tools in the biological and biomedical sciences, in the characterization of the immune system, study the mechanisms by which pathogens cause disease, develop improved diagnostic assays, and identify antigens from pathogens that can be used in subunit vaccines. Because of our research needs, we started developing mAbs for use in food and companion animal research and diagnostic medicine in 1979. To encourage other investigators to use mAb technology, we sponsored the first international symposium and workshop ‘Impact of Monoclonal Antibody Technology on Animal and Plant Agricultural Research’ in June of 1982. We also participated in a workshop sponsored by the National Research Council of the National Academy of Science on ‘Priorities in Biotechnology Research for International Development held in July of 1982, a symposium sponsored by the USDA ‘Hybridoma Technology in Agricultural and Veterinary Research’ held in Oct. of 1983 and an international conference sponsored by the International Laboratory for Research on Animal Diseases ‘The Ruminant Immune System In Health and Disease’ held in Kenya Africa in September 1983. In 1984, we co-sponsored a meeting with Australia ‘Characterization of the Bovine Immune System and the Genes Regulating Expression of Immunity with Particular Reference to their Role in Disease Resistance’ held in Honolulu, Hawaii. During this period of time, we developed some of the first sets of mAbs for use in the study of the immune system in food and companion animals. We also participated in all the international workshops to characterize the first sets of mAbs.
Goals
The Washington State University Monoclonal Antibody Center was established in 1982 with the following goals:
- Provide a central facility for the production of mAbs for investigators that do not have the facilities or expertise to produce mAbs for their research.
- Develop and use mAbs to study the mechanisms regulating the immune response to pathogens and candidate subunit vaccines in veterinary species.
- Provide a source of mAbs for the research community for use in food and companion animal research.
- Provide graduate and professional training in the use of mAb technology in research and the development of diagnostic reagents.
- Provide graduate and professional training in the use of mAbs in immunology and flow cytometry.
- Collaborate with investigators requiring expertise and resources available through the center to conduct studies in immunology.
- Aid in the development of clinical flow cytometry diagnostic services in veterinary medicine.